drugset / Trial / NCT01084525
OTO-104 for Meniere's Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety of OTO-104 in subjects with unilateral Meniere's disease. The effectiveness of OTO-104 to reduce the symptoms of Meniere's disease will also be evaluated.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-03
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 3 mg | Other |
| Subject | Dexamethasone | Small molecule | 12 mg | Other |